Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Klepper

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|June 6, 2003
Neuroglycopenia in normoglycaemic patients, and the potential benefit of ketosisM A A P Willemsen, R J Soorani-Lunsing, E Pouwels, et al.
Pediatric Research|December 10, 1999
GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitroJ Klepper, J Fischbarg, J C Vera, et al.
Pediatric Research|July 31, 2001
Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitroY Y Ho, H Yang, J Klepper, et al.
Neuropediatrics|March 12, 2010
Autosomal recessive inheritance of GLUT1 deficiency syndromeJ Klepper, H Scheffer, M F Elsaid, et al.
The Journal of International Medical Research|January 1, 1986
Carteolol treatment of essential hypertension: a long-term study of safety and efficacyR R Luther, C J Maurath, M J Klepper, et al.
Human Molecular Genetics|January 4, 2001
Autosomal dominant transmission of GLUT1 deficiencyJ Klepper, M Willemsen, A Verrips, et al.
Journal of Human Hypertension|April 1, 1990
Effects of terazosin on serum lipid levels in hypertensive blacksR R Luther, M J Klepper, C J Maurath, et al.
Journal of Human Hypertension|April 1, 1990
Efficacy of terazosin in the treatment of essential hypertension in blacksR R Luther, M J Klepper, C J Maurath, et al.
Journal of Inherited Metabolic Disease|January 31, 2003
Introduction of a ketogenic diet in young infantsJ Klepper, B Leiendecker, R Bredahl, et al.
Neurochemical Research|May 5, 1999
Defective glucose transport across brain tissue barriers: a newly recognized neurological syndromeJ Klepper, D Wang, J Fischbarg, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Diabetic Medicine : a Journal of the British Diabetic Association|June 6, 2003
Neuroglycopenia in normoglycaemic patients, and the potential benefit of ketosisM A A P Willemsen, R J Soorani-Lunsing, E Pouwels, et al.
Pediatric Research|December 10, 1999
GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitroJ Klepper, J Fischbarg, J C Vera, et al.
Pediatric Research|July 31, 2001
Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitroY Y Ho, H Yang, J Klepper, et al.
Neuropediatrics|March 12, 2010
Autosomal recessive inheritance of GLUT1 deficiency syndromeJ Klepper, H Scheffer, M F Elsaid, et al.
The Journal of International Medical Research|January 1, 1986
Carteolol treatment of essential hypertension: a long-term study of safety and efficacyR R Luther, C J Maurath, M J Klepper, et al.
Human Molecular Genetics|January 4, 2001
Autosomal dominant transmission of GLUT1 deficiencyJ Klepper, M Willemsen, A Verrips, et al.
Journal of Human Hypertension|April 1, 1990
Effects of terazosin on serum lipid levels in hypertensive blacksR R Luther, M J Klepper, C J Maurath, et al.
Journal of Human Hypertension|April 1, 1990
Efficacy of terazosin in the treatment of essential hypertension in blacksR R Luther, M J Klepper, C J Maurath, et al.
Journal of Inherited Metabolic Disease|January 31, 2003
Introduction of a ketogenic diet in young infantsJ Klepper, B Leiendecker, R Bredahl, et al.
Neurochemical Research|May 5, 1999
Defective glucose transport across brain tissue barriers: a newly recognized neurological syndromeJ Klepper, D Wang, J Fischbarg, et al.
Pageof 3